Blood Sugar, High Frontal Alpha, and Anger in Fibromyalgia Syndrome

REFERENCES

• Shelley-Tremblay J, Ernst E, Kline JP: The effect of sucrose consumption on left-frontal asymmetry and anger in persons with fibromyalgia syndrome. J Musculoske Pain 17(4): in press.
   Google Scholar
• Eisinger J, Plantamura A, Ayavou T: Glycolysis abnormalities in fibromyalgia. J Am Coll Nutr 13: 144–148, 1994.
   PubMed Web of Science ®Google Scholar
• Kellgren JHL: Observations on referred pain arising from muscle. Clinical Sci 3: 175–190, 1939.
   Google Scholar
• Kim IJ, Kang, YK, Kim DH, Hwang M: Referred pain pattern of the abductor pollicis brevis muscle and its possible mechanism. J Musculoske Pain 17(4): in press.
   Google Scholar
• Bentsen SB, Wahl AK, Strand LI, Hanestad BR: Pain and disability in chronic low back pain patients treated using instrumented fusion. J Musculoske Pain 17(4): in press.
   Google Scholar
• de GG: Epidemiology and social costs of low back pain and fibromyalgia. Clin J Pain 7(Suppl 1): S1–S7,1991.
   Google Scholar
• McBeth J, Jones K, McBeth J, Jones K: Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 21: 403–425, 2007.
   PubMed Web of Science ®Google Scholar
• Fonseca Lopes de Sousa KS, Orfale AG, Meireles SM, Leite JR, Natour J: Assessmentn of biofeedback program to treat chornic low back pain patients. J Musculoske Pain 17(4): in press.
   Google Scholar
• Demoulin C, Grosdent S, Bury T, Croisier JL, Maquet D, Lehance C, : Cardiovascular responses to static assessments of trunk muscles. J Musculoske Pain 17(4): in press.
   Google Scholar
• Van Houdenhove B, Luyten P, Egle UT: Stress as a key concept in chronic widespread pain and fatigue disorders. J Musculoske Pain 17(4): in press.
   Google Scholar
• Malmberg AB, Yaksh TL: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 257: 1276–1279, 1992.
   PubMed Web of Science ®Google Scholar
• Woolf CJ, Garabedian BS, Ma QP, Crilly P, Winter J: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62: 327–331, 1994.
   PubMed Web of Science ®Google Scholar
• Andersen ML, Nascimento DC, Machado RB, Roizenblatt S, Moldofsky H, Tufik S: Sleep disturbance induced by substance P in mice. Behav Brain Res 167: 212–218, 2006.
   PubMed Web of Science ®Google Scholar
• Berrettini WH, Rubinow DR, Nurnberger JI Jr, Simmons-Alling S, Post RM, Gershon ES: CSF substance P in affective disorders. Biol Psychiatry 20: 965–968, 1985.
   PubMed Web of Science ®Google Scholar
• Herpter I, Lleb K: Substance P and substance P receptor antagonists in the pathogenesis and treatment of affective disorders. World J Biol Psychiatry 4: 56–63, 2003.
   PubMed Web of Science ®Google Scholar
• Kramer S, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, : Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640–1645, 1998.
   PubMed Web of Science ®Google Scholar
• Nutt D: Substance-P antagonists: A new treatment for depression?. Lancet 352: 1644–1646, 1999.
   Web of Science ®Google Scholar
• Russell IJ: The promise of substance P inhibitors in fibromyalgia. [Review] [48 refs]. Rheum Dis Clin North Am 28: 329–342, 2002.
   PubMed Web of Science ®Google Scholar
• Scicchitano R, Biennenstock J, Stanisz AM: In vivo immunomodulation by the neuropeptide substance P. Immunology 63: 733–735, 1988.
   PubMed Web of Science ®Google Scholar
• Larsen PJ, Jessop D, Patel H, Lightman SL, Chowdrey HS: Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. J Neuroendocrinol 5: 99–105, 1993.
   PubMed Web of Science ®Google Scholar
• Jessop DS, Renshaw D, Larsen PJ, Chowdrey HS, Harbuz MS: Substance P is involved in terminating the hypothalamo-pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors. Stress 3: 209–220, 2000.
   PubMedGoogle Scholar
• Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S, : Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78(2): 153–155,1998.
   PubMed Web of Science ®Google Scholar
• Yunus MB: Central sensitivity syndrome: An overview. J Musculoske Pain 17(4): in press.
   Google Scholar
• Fernández-Carnero J, Fernández-de-las-Peñas C, Cleland JA: Mulligan's mobilization with movement and muscle trigger point dry needling for the management of chronic lateral epicondylalgia: A case report. J Musculoske Pain 17(4): in press.
   Google Scholar